Clean Science Subsidiary Completes Advanced HALS Trials; Commercial Launch Slated for H2 FY27
Clean Science and Technology Ltd · Others (Uncategorized) · 30 Oct 2026, 12:34 am
Clean Science Subsidiary Completes Advanced HALS Trials; Commercial Launch Slated for H2 FY27 Clean Science and Technology's wholly owned subsidiary, Clean Fino-Chem Limited, has successfully completed product trials for advanced grades of HALS products developed in collaboration with Geneus Chem AG. The products achieved internal quality benchmarks and international regulatory standards, demonstrating commercial viability and optimum efficiency. Commercial launch of the new product range is expected to commence in H2 FY26–27, supporting the company's strategic growth objectives and expanding its market presence.
Original exchange filing (PDF)
More announcements from Clean Science and Technology Ltd
- Enclosed is the Earning Call Transcript for Q2 FY 2026-27 held on 31st October, 2026 · 05 Nov 2026
- Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the audio recording of the Earnings Call for the quarter .... · 31 Oct 2026
- Enclosed is the Investors Presentation Q2FY27 · 31 Oct 2026
- Further to our letter dated 17th October, 2026 and in compliance with Regulation 30 read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ( SEBI Listing Regulations, 2015 ) we hereby inform you that, the Board of Directors of the Company at their meeting held today viz. Saturday, 31st October, 2026, have approved the Un-Audited Standalone and Consolidated Financial Results for the Quarter and Half Year ended 30th S · 31 Oct 2026
- Enclosed are the unaudited results for the Q2FY27 · 31 Oct 2026
- Further to our letter dated 17th October, 2026 and in compliance with Regulation 30 read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure .... · 31 Oct 2026
- In terms of the referred Regulation 30 read with Schedule III - Part A of SEBI Listing Regulations, 2015, we would like to inform you that, a conference call for analysts and investors .... · 31 Oct 2026
- Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, intimation is hereby given that, a meeting of the Board of Directors of the Company will be held on Saturday, 31st October, 2026, to inter alia, consider and approve the Un-audited Standalone and Consolidated Financial Results for the Quarter and Half Year ended 30th September, 2026. · 31 Oct 2026
